Ocrelizumab: Solution concentrate for I.V. infusion 300 mg in 10 mL; Ocrevus® Page last updated: 30 October 2020 Public Summary Document (PSD) July 2020 PBAC Meeting - (PDF 1314KB) Public Summary Document (PSD) July 2020 PBAC Meeting - (Word 95KB)